Benign neoplasm: Skin of other and unspecified parts of face

CD2_BENIGN_SKIN_FACE_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D23.3& Hospital discharge: ICD-9 — 2163 Hospital discharge: ICD-8 — 21604 Hospital discharge: excluded ICD-9 — 2163A Cause of death: ICD-10 — D23.3& Cause of death: ICD-9 — 2163 Cause of death: ICD-8 — 21604 Cause of death: excluded ICD-9 — 2163A 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D23
Name in latin: Neoplasma benignum cutis faciei

NAME	CD2_BENIGN_SKIN_FACE_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D233
HD_ICD_9	2163
HD_ICD_8	21604
HD_ICD_10_EXCL
HD_ICD_9_EXCL	2163A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D233
COD_ICD_9	2163
COD_ICD_8	21604
COD_ICD_10_EXCL
COD_ICD_9_EXCL	2163A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Skin of other and unspecified parts of face based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Skin of other and unspecified parts of face

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4428	2568	1860
Unadjusted period prevalence (%)	0.85	0.88	0.82
Median age at first event (years)	59.77	56.02	64.96

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3993: Matched controls
39928

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

9559.4

323.0

3828

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

513

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

323.0

410

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

47.0

323.0

1603

561

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

63.9

323.0

663

124

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

357.4

323.0

890

L57.0

ICD-10 Finland

Actinic keratosis

7.4

318.1

832

1365

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

25.9

282.5

402

172

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

6.8

278.5

775

1368

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

247.5

235

C61

ICD-10 Finland

Malignant neoplasm of prostate

267.6

247.4

251

PJA12

NOMESCO Finland

Sentinel node biopsy

332.2

216.9

218

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

8.2

202.0

479

650

130

Kela drug reimbursment

Malignant tumour

+∞

194.3

185

115

Kela drug reimbursment

Breast cancer

+∞

190.1

181

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

184.2

185.6

193

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

239.6

179.0

183

SPAT1153

SPAT

Removal of sutures

2.6

158.1

1553

7751

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

799.0

157.5

154

116

Kela drug reimbursment

Prostate cancer

+∞

152.0

145

ZZR00

NOMESCO Finland

Flap of skin

34.9

145.2

190

R23.8

ICD-10 Finland

Other and unspecified skin changes

3.4

144.8

803

2720

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

664.5

131.3

129

H02AB02

ATC

dexamethasone; systemic

14.6

128.0

221

159

DHB00

NOMESCO Finland

Excision of lesion of external nose

53.7

121.0

145

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

213.2

120.3

124

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

11.2

118.1

231

218

ZXC50

NOMESCO Finland

Cryotherapy

9.7

115.1

243

265

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

10.2

113.8

233

240

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

5.3

110.4

363

744

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

107.8

103

S18

ICPC

Laceration/cut

2.1

106.0

1733

10546

A04AA02

ATC

granisetron; systemic, transdermal

106.7

104.5

114

21604

ICD-8 Finland

Benign neoplasm of skin, Partis alterius facici sive faciei non definita

+∞

101.5

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

98.3

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

7.2

90.3

230

338

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

88.9

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

99.4

88.3

TQW99

NOMESCO Finland

Other minor procedure on skin

5.6

86.2

264

495

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

856.3

85.9

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

83.6

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

8.5

83.4

189

232

WF002

NOMESCO Finland

Radical radiotherapy

62.1

83.1

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

11.7

82.7

157

139

L82

ICD-10 Finland

Seborrhoeic keratosis

2.5

82.5

730

3234

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

81.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

80.5

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

206.6

78.5

HAC20

NOMESCO Finland

Total mastectomy

75.9

78.5

DAB00

NOMESCO Finland

Excision of lesion of auricle

23.5

77.4

112

WF003

NOMESCO Finland

Adjuvant radiotherapy

163.2

76.3

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

15.1

74.5

126

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

13.2

73.2

131

102

L02BA01

ATC

tamoxifen; oral

91.9

73.2

D06BB10

ATC

imiquimod; topical

4.6

71.9

265

608

XQ845

NOMESCO Finland

Dermatoscopy

14.8

71.1

121

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

358.5

70.8

L02BB03

ATC

bicalutamide; oral

+∞

70.0

L02AE02

ATC

leuprorelin; implant, parenteral

14.8

69.3

118

C50.99

ICD-10 Finland

Breast, unspecified

+∞

68.9

ZXC15

NOMESCO Finland

Use of photodynamic technique

15.4

68.1

114

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

38.2

67.5

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

658.8

66.1

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

64.0

1062

6183

A03FA01

ATC

metoclopramide; systemic, rectal

2.4

62.3

575

2571

HAB40

NOMESCO Finland

Wedge excision of mammary gland

19.4

62.0

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

317.7

61.5

S77

ICPC

Malignant neoplasm of skin

49.5

60.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

306.9

59.5

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

62.8

58.5

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

58.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

58.5

J01DB01

ATC

cefalexin; oral

1.8

56.5

3095

26106

JN4BD

NOMESCO Finland

Extensive body CT

3.5

56.3

282

850

L02BG04

ATC

letrozole; oral

9.4

54.3

115

126

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

54.3

L01BC06

ATC

capecitabine; oral

+∞

54.3

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

117.7

53.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

535.0

53.6

A04AA55

ATC

palonosetron, combinations; systemic

+∞

53.2

L03AA13

ATC

pegfilgrastim; parenteral

+∞

53.2

Y77

ICPC

Malignant neoplasm prostate

136.8

50.9

XQ848

NOMESCO Finland

Dermatological photography

5.5

50.1

154

289

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

50.1

NK6AN

NOMESCO Finland

Total body bone isotope imaging

33.0

49.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

48.0

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

48.0

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

168.7

47.9

HA1AA

NOMESCO Finland

X-ray mammography

4.5

47.4

177

411

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

47.0

S82

ICPC

Naevus/mole

2.3

46.9

499

2374

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

45.9

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

5.2

45.0

145

288

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

442.5

44.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

44.1

609

3240

A04AA01

ATC

ondansetron; systemic, rectal

4.8

43.9

153

331

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

43.8

JN4AD

NOMESCO Finland

Body CT examination

3.8

43.5

196

541

C50

ICD-10 Finland

Malignant neoplasm of breast

432.2

43.3

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

432.2

43.3

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

42.8

ZZA50

NOMESCO Finland

Full thickness skin graft

51.6

42.7

SPAT1263

SPAT

Sampling

1.6

42.5

1629

11969

WX110

NOMESCO Finland

Local anesthesy

1.6

41.9

2405

19520

ZX090

NOMESCO Finland

Other technic of radiotherapy

113.7

41.8

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

21.0

41.8

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

41.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

41.7

1559

11364

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

27.5

41.6

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

41.3

1562

11408

S29

ICPC

Skin symptom/complaint other

1.9

41.3

657

3684

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

10.6

41.1

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

24.5

41.0

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

5.3

41.0

130

254

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

40.7

UJF32

NOMESCO Finland

Coloscopy

1.7

40.5

953

6090

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

5.6

40.1

120

219

L03AA02

ATC

filgrastim; parenteral

38.9

39.7

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.4

39.7

206

637

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

3.2

39.3

214

686

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

391.2

39.1

CBB30

NOMESCO Finland

Excision of lesion of eyelid

4.1

38.7

157

395

Z51.5

ICD-10 Finland

Palliative care

4.6

38.7

139

311

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

38.6

ZZA00

NOMESCO Finland

Split skin graft

4.4

38.3

143

332

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.4

38.1

143

334

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

380.9

38.1

UKC02

NOMESCO Finland

Cystoscopy

1.9

37.5

578

3193

XX3DW

NOMESCO Finland

Time consuming IT work

3.0

37.2

231

811

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

36.5

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

54.3

36.4

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

360.5

36.0

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

360.5

36.0

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

35.5

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.3

35.5

111

214

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

35.2

1166

8144

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

34.4

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

34.4

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.8

33.9

116

247

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

3.4

33.7

170

515

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.7

33.5

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

33.4

ZX080

NOMESCO Finland

Image guided radiotherapy

329.7

32.9

N02BE01

ATC

paracetamol; systemic, rectal

1.6

32.7

3204

28568

SPAT1312

SPAT

General health counselling

1.6

32.4

1178

8389

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

32.3

127

Kela drug reimbursment

Transplant complication

6.3

32.1

141

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

31.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

31.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

31.3

A04AD12

ATC

aprepitant; systemic

+∞

31.3

XKD00

NOMESCO Finland

Uroflowmetry

1.9

31.1

516

2914

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

30.9

531

3037

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

315.2

30.9

D23.4

ICD-10 Finland

Benign neoplasm: Skin of scalp and neck

6.8

30.5

117

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

30.2

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

30.2

2163X

ICD-9 Finland

Benign neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON BEN KASVAIN,TARK MÄÄRITT HYVÄNLAAT KA]

+∞

30.2

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

58.8

30.1

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

304.6

29.8

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

304.6

29.8

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

29.2

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

29.2

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

29.2

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.7

29.1

682

4300

S79

ICPC

Neoplasm skin benign/unspecified

4.9

29.0

198

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

151.1

28.7

SPAT1301

SPAT

No procedures

1.5

28.7

1207

8841

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

44.1

28.7

A02BC02

ATC

pantoprazole; systemic

1.5

28.2

2312

19420

L72.1

ICD-10 Finland

Trichilemmal cyst

2.4

28.2

243

1034

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

28.1

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

4.9

28.1

196

I78.1

ICD-10 Finland

Naevus, non-neoplastic

3.9

28.0

117

304

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

27.8

489

2811

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

27.7

417

2269

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

27.5

825

5554

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

27.4

273

1246

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

27.1

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

27.1

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

140.9

26.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.5

26.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

26.1

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

26.1

X76

ICPC

Malignant neoplasm breast female

94.0

25.7

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

135.9

25.6

N02AA05

ATC

oxycodone; systemic

1.9

25.6

417

2330

D06BX02

ATC

ingenol mebutate; topical

5.4

25.3

145

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

10.5

25.2

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

35.8

25.2

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

25.0

DAB10

NOMESCO Finland

Partial excision of auricle

+∞

25.0

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

25.0

UDC00

NOMESCO Finland

Ear microscopy

2.1

24.8

286

1394

A79

ICPC

Malignancy NOS

90.6

24.7

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

130.8

24.6

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

3.0

24.6

147

503

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

24.6

1339

10280

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

27.7

24.4

WXQ99

NOMESCO Finland

Other light therapy

56.4

24.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

24.0

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

24.0

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

13.3

23.7

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

87.3

23.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

23.7

1002

7284

WF004

NOMESCO Finland

Palliative radiotherapy

241.3

23.7

A98

ICPC

Health maint/preventive medicine

1.7

23.6

3596

33639

L02BG03

ATC

anastrozole; oral

26.9

23.5

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

46.9

23.3

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

54.3

23.0

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

10.3

23.0

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

22.9

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

22.9

L02BX02

ATC

degarelix; parenteral

+∞

22.9

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

22.9

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

15.5

22.8

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

13.6

22.7

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

231.2

22.6

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

12.6

22.6

D23.0

ICD-10 Finland

Benign neoplasm: Skin of lip

11.5

22.1

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

21.9

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

21.9

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

21.9

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

21.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

80.5

21.7

S21

ICPC

Skin texture symptom/complaint

1.8

21.6

424

2517

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

221.1

21.6

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

115.6

21.6

C90.0

ICD-10 Finland

Multiple myeloma

115.6

21.6

Z94.0

ICD-10 Finland

Kidney transplant status

5.7

21.2

108

J01MA02

ATC

ciprofloxacin; systemic

1.4

21.2

1320

10322

B07.9

ICD-10 Finland

Verruca simplex

2.9

21.0

127

440

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

20.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

20.8

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

20.8

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

20.8

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

20.8

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

20.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

211.0

20.6

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

211.0

20.6

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

211.0

20.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

110.6

20.6

9733

FHL

Excision of skin change in operating room or anesthesia

4.4

20.5

169

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

20.1

1052

7940

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.4

19.9

170

721

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

19.9

586

3895

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

19.8

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

19.8

L02BG06

ATC

exemestane; oral

200.9

19.6

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

200.9

19.6

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

3.4

19.4

279

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

19.3

188

851

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

19.3

587

3934

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

19.0

558

3705

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

19.0

726

5127

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

4.4

18.9

160

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

9.6

18.8

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.7

18.8

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

15.9

18.8

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

18.8

2163G

ICD-9 Finland

Benign neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON BEN KASVAIN,MUU MÄÄR HYVÄNLAAT KASV]

+∞

18.8

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

18.8

S26

ICPC

Fear of cancer of skin

6.8

18.7

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

18.8

18.6

WZC30

NOMESCO Finland

Teaching

1.8

18.5

318

1806

B01AB05

ATC

enoxaparin; parenteral

1.4

18.5

918

6841

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.8

18.5

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

18.4

256

1349

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.4

18.3

151

J01DA01

ATC

[U] cefalexin; systemic

1.3

18.3

2238

19424

L04AA06

ATC

mycophenolic acid; systemic

3.9

18.3

194

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

18.3

181

827

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

18.2

258

1367

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

18.1

1156

9017

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

18.1

1574

12937

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

18.1

425

2657

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

17.7

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

17.7

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

17.7

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.9

17.7

268

1459

L04AD01

ATC

ciclosporin; systemic

3.7

17.5

212

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

17.4

2326

20382

S04

ICPC

Lump/swelling localized

1.8

17.4

299

1696

J01CA04

ATC

amoxicillin; systemic

1.4

17.4

2846

25749

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

17.3

1785

15036

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.7

17.0

114

424

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

17.0

1205

9553

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

16.9

172

796

J05AB01

ATC

aciclovir; systemic

1.5

16.8

686

4901

ZZS00

NOMESCO Finland

Rotation flap

63.6

16.7

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

16.7

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

16.7

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

16.7

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

16.7

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

16.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

16.7

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

16.7

SPAT1325

SPAT

Vaccination

1.4

16.7

1232

9824

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

35.2

16.7

SPAT1310

SPAT

Counselling related to known health issue

1.4

16.6

1108

8686

128

Kela drug reimbursment

Cancers of female genital organs

90.4

16.6

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.0

16.5

332

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

16.5

321

1896

Z01.2

ICD-10 Finland

Dental examination

1.4

16.4

1295

10431

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

16.4

634

4476

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

16.2

296

1713

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

47.7

16.0

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

16.0

867

6542

S08

ICPC

Skin colour change

2.1

16.0

173

824

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.5

15.7

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

15.6

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

15.6

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

15.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

15.6

L02BB04

ATC

enzalutamide; oral

+∞

15.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

15.6

547

3774

JN4CD

NOMESCO Finland

Very extensive body CT

3.3

15.6

239

J01AA02

ATC

doxycycline; systemic

1.3

15.6

2799

25410

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

15.5

2065

17939

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.5

15.5

208

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

15.5

525

3597

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

15.5

467

3113

ZXA00

NOMESCO Finland

Right side

1.4

15.4

891

6798

SPAT1211

SPAT

Application of soft bandage

1.7

15.3

303

1800

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.2

15.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

15.2

384

2442

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

15.2

216

1147

L57.9

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation, unspecified

28.7

15.2

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

14.9

697

5107

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

14.9

343

2129

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.2

14.8

ZXC96

NOMESCO Finland

Robot assisted procedure

6.0

14.8

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

56.9

14.8

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

56.9

14.8

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

14.8

1811

15508

R31

ICD-10 Finland

Unspecified haematuria

1.7

14.7

305

1834

EAA10

NOMESCO Finland

Excision of lesion of lip

4.5

14.7

118

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

14.7

1700

14437

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

14.6

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

+∞

14.6

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

14.6

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

14.6

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

14.6

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

14.6

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

80.4

14.6

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

80.4

14.6

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

80.4

14.6

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

150.5

14.5

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

150.5

14.5

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

14.4

613

4410

E0000UV

ATC

1.3

14.2

1257

10249

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

13.4

14.2

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.8

14.2

233

1303

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.9

14.2

A07AA02

ATC

nystatin; oral

1.9

14.1

210

1137

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

42.6

14.1

ZXC10

NOMESCO Finland

Use of laser

2.9

14.1

301

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

13.9

669

4925

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

30.1

13.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.8

1600

13549

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

11.4

13.8

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

13.7

104

415

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

13.7

210

1149

WX702

NOMESCO Finland

Supraglottic ventilation device

2.1

13.6

151

728

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

75.4

13.6

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

13.5

183

955

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

+∞

13.5

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

13.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

13.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.5

G04BE03

ATC

sildenafil; oral

7.9

13.5

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

140.4

13.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

140.4

13.4

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

140.4

13.4

WX402

NOMESCO Finland

General anaesthesia

1.6

13.4

384

2523

H61.2

ICD-10 Finland

Impacted cerumen

1.9

13.4

202

1099

H02AB06

ATC

prednisolone; systemic

1.3

13.3

1576

13366

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.3

13.2

198

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

13.0

311

1954

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.4

12.9

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

12.9

830

6422

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

12.9

583

4235

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

12.9

1233

10142

ZXC20

NOMESCO Finland

Use of chemical agents

3.6

12.8

161

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

12.8

1419

11911

KMAK

NOMESCO Finland

1.3

12.8

1657

14201

SPAT1216

SPAT

Assessment of functional ability

1.4

12.7

557

4021

EKB00

NOMESCO Finland

Excision of lesion of cheek

9.7

12.7

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.0

12.7

172

899

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

70.1

12.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

12.6

105

445

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

12.5

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

12.5

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

12.5

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

12.5

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

12.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

12.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

12.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

12.5

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

10.1

12.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

130.4

12.4

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.5

12.4

160

A02BA02

ATC

ranitidine; systemic

1.4

12.4

684

5154

A02BC05

ATC

esomeprazole; systemic

1.3

12.3

1347

11265

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.1

12.2

112

D36.7

ICD-10 Finland

Benign neoplasm: Other specified sites

8.4

12.2

M05BX04

ATC

denosumab; parenteral

2.1

12.2

141

693

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

12.2

158

811

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

12.2

992

7953

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

5.9

12.2

H25.8

ICD-10 Finland

Other senile cataract

1.5

12.2

404

2746

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.0

12.2

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

12.2

101

423

L72.0

ICD-10 Finland

Epidermal cyst

4.0

12.2

122

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

12.2

285

1776

SPAT1254

SPAT

Administration of medicine

1.5

12.1

495

3520

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

18.1

12.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

12.0

1063

8624

R01AD09

ATC

mometasone; nasal

1.3

12.0

1404

11841

C08CA01

ATC

amlodipine; oral

1.3

12.0

1244

10323

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

11.9

141

700

Z31.5

ICD-10 Finland

Genetic counselling

2.3

11.9

109

483

QAE15

NOMESCO Finland

Excision of other superficial lesion of skin from head and neck

13.4

11.9

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

11.9

399

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.8

2088

18532

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.9

11.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

11.8

235

1398

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

11.8

1369

11528

QAA10

NOMESCO Finland

Incision of skin of head or neck

14.7

11.8

A02BC03

ATC

lansoprazole; oral

1.3

11.7

992

7995

N03AX16

ATC

pregabalin; oral

1.4

11.6

732

5632

ZX112

NOMESCO Finland

Subcutaneous

4.3

11.6

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

12.6

11.6

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

11.5

109

491

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

11.5

234

1404

153

Kela drug reimbursment

Lenalidomid

+∞

11.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

11.5

L04AX04

ATC

lenalidomide; oral

+∞

11.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

11.5

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

11.5

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

11.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

11.5

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

+∞

11.5

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

11.5

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

11.5

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

11.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

11.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

11.5

N02AX02

ATC

tramadol; systemic, rectal

1.3

11.4

1343

11308

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

120.3

11.4

Z51.0

ICD-10 Finland

Radiotherapy session

120.3

11.4

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

4.5

11.4

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

11.3

197

1126

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

35.1

11.3

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

4.4

11.2

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.6

11.1

138

ZX120

NOMESCO Finland

Intravenous

1.7

11.1

220

1307

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

8.0

11.1

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

13.9

10.9

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

43.4

10.9

J02AC01

ATC

fluconazole; systemic

1.3

10.9

1227

10266

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

10.9

130

648

D06BX01

ATC

metronidazole; topical

1.6

10.8

321

2126

N05CF01

ATC

zopiclone; oral

1.3

10.7

1059

8704

D18.0

ICD-10 Finland

Haemangioma, any site

2.6

10.7

296

WW500

NOMESCO Finland

Blood transfusion

2.7

10.6

273

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

10.6

1112

9205

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

60.1

10.6

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

10.6

207

1230

L02AE03

ATC

goserelin; implant

6.0

10.6

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

6.0

10.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

10.5

205

1215

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

10.5

794

6278

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

10.5

1341

11384

ZXC12

NOMESCO Finland

Pulse colorlaser

10.0

10.5

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.6

10.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

110.3

10.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

110.3

10.4

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

110.3

10.4

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

110.3

10.4

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

110.3

10.4

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

10.4

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

10.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

10.4

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

10.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

10.4

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

10.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

10.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

10.4

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

10.4

AA1AD

NOMESCO Finland

CT of head and brain

1.3

10.4

804

6380

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

10.3

260

1657

L91.0

ICD-10 Finland

Hypertrophic scar

3.6

10.3

127

J01MA12

ATC

levofloxacin; systemic

1.4

10.2

538

4010

J01EA01

ATC

trimethoprim; systemic

1.3

10.2

843

6748

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

9.6

10.2

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

4.7

10.2

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

10.2

1235

10407

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

10.1

203

1214

R50.9

ICD-10 Finland

Fever, unspecified

1.5

10.1

371

2578

A12AA04

ATC

calcium carbonate; oral

2.9

10.1

204

R13

ICD-10 Finland

Dysphagia

1.7

10.1

195

1153

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

10.1

312

2089

R51.80

ICD-10 Finland

Headache

1.4

10.0

417

2974

SPAT1260

SPAT

Consultation of another employee

1.4

10.0

580

4393

KAC10

NOMESCO Finland

Total nephrectomy with capsule

11.3

10.0

HA1HA

NOMESCO Finland

Tomosynthesis mammography

11.3

10.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

10.0

1316

11197

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.9

901

7307

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.9

9.9

195

B01AB10

ATC

tinzaparin; parenteral

1.9

9.9

142

764

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

9.9

183

1071

WZA90

NOMESCO Finland

Other doctors statement

1.3

9.8

677

5274

QCA50

NOMESCO Finland

Cryotherapy of skin of upper limb

12.2

9.8

R4135

NOMESCO Finland

Rehabilitation for hearing problems

2.5

9.8

299

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

26.1

9.8

L04AA01

ATC

[U] ciclosporin; systemic

2.9

9.7

192

R01AD08

ATC

fluticasone; nasal

1.3

9.7

855

6903

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.7

1251

10610

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.3

9.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

9.7

899

7309

A06AD11

ATC

lactulose; oral

1.4

9.7

467

3425

C08CA02

ATC

felodipine; oral

1.5

9.7

328

2244

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

9.6

514

3839

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

9.6

163

926

XX1XN

NOMESCO Finland

Other isotope examination

55.1

9.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

55.1

9.6

WX002

NOMESCO Finland

Sedation and analgesia

1.4

9.6

593

4536

G04CA02

ATC

tamsulosin; oral

1.3

9.6

688

5386

M01AH05

ATC

etoricoxib; oral

1.2

9.6

1865

16566

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.5

9.6

124

ZQZ00

NOMESCO Finland

Treatment of several skin areas

9.1

9.5

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

5.2

9.5

J01FF01

ATC

clindamycin; systemic

1.3

9.5

825

6650

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

17.6

9.4

L02BX03

ATC

abiraterone; oral

+∞

9.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

9.4

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

9.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

9.4

K62.7

ICD-10 Finland

Radiation proctitis

+∞

9.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

9.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

9.4

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

9.4

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

9.4

HAC25

NOMESCO Finland

Radical mastectomy

+∞

9.4

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

9.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

9.4

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

9.4

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

9.4

L01AX03

ATC

temozolomide; systemic

+∞

9.4

C44.82

ICD-10 Finland

Overall spinocellular carcinoma of the skin

+∞

9.4

C44.49

ICD-10 Finland

Malignant tumor of the skin of the scalp and of the neck other or unspecified histology

+∞

9.4

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

9.4

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

9.4

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

9.4

178

1047

SPAT1262

SPAT

Handing over of treatment supplies

1.4

9.4

561

4272

CBA10

NOMESCO Finland

Biopsy of eyelid

4.1

9.2

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

9.2

185

1106

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

6.0

9.2

XLA10

NOMESCO Finland

1.8

9.2

148

829

D21.0

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of head, face and neck

5.7

9.2

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

9.2

746

5952

D01AE16

ATC

amorolfine; topical

1.5

9.2

371

2632

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

9.1

287

1929

ZXA05

NOMESCO Finland

Left side

1.3

9.1

803

6480

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

9.1

668

5249

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.1

9.1

SPAT1255

SPAT

Intravenous administration of medicine

1.7

9.1

199

1223

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

9.0

338

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.3

9.0

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

36.8

9.0

TKE10

NOMESCO Finland

Puncture of prostate

36.8

9.0

SPAT1234

SPAT

Support of social functional capacity

1.7

9.0

173

1023

137

Kela drug reimbursment

Uraemia requiring dialysis

3.9

9.0

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

9.0

696

5512

P01AB01

ATC

metronidazole; oral, rectal

1.2

8.9

1231

10501

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

24.0

8.9

SPAT1172

SPAT

Guidance concerning hydration

2.2

8.9

386

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.8

704

5597

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

8.8

108

547

WX704

NOMESCO Finland

Intubation

1.7

8.8

186

1130

N63

ICD-10 Finland

Unspecified lump in breast

1.8

8.7

138

766

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

8.7

426

3131

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.7

2245

20458

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

8.6

909

7500

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

11.6

8.6

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

16.3

8.5

7151

FHL

Kidney transplantation

16.3

8.5

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

16.3

8.5

S15

ICPC

Foreign body in skin

1.7

8.5

167

993

SPAT1097

SPAT

Recording of ECG

1.4

8.5

489

3696

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

27.6

8.5

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

27.6

8.5

TDA90

NOMESCO Finland

Removal wax from ear

2.8

8.4

183

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

8.4

139

782

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

7.3

8.4

JAH01

NOMESCO Finland

Laparoscopy

2.0

8.4

103

521

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

90.2

8.4

G04BD12

ATC

mirabegron; oral

1.5

8.4

315

2203

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

8.3

348

2482

K03.66

ICD-10 Finland

Tooth plaque

1.7

8.3

184

1135

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

8.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

8.3

180

Kela drug reimbursment

Interferon alfa

+∞

8.3

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

8.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

8.3

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

8.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

8.3

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

8.3

C44.69

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology

+∞

8.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

8.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

8.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

8.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

8.3

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

+∞

8.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

8.3

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

8.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

8.3

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

8.3

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

8.3

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

8.3

195

1222

SPAT1229

SPAT

Assessment of need for aid

1.5

8.3

270

1831

J01FA10

ATC

azithromycin; systemic

1.2

8.3

1797

16050

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

8.3

149

864

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.3

220

1424

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.4

8.3

282

G03HA01

ATC

cyproterone; systemic

9.4

8.3

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

8.3

712

5716

SBB10

NOMESCO Finland

Teeth copy

1.7

8.2

159

942

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

2.6

8.2

228

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

8.2

126

692

WX720

NOMESCO Finland

Own respiration

1.9

8.2

110

576

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

2.5

8.2

239

A11CC03

ATC

alfacalcidol; systemic

2.3

8.2

335

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

14.5

8.2

TQW20

NOMESCO Finland

Tatoe

14.5

8.2

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.9

8.2

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

8.1

212

1364

WX290

NOMESCO Finland

Other blockade of nerve

1.2

8.1

1214

10425

H75

ICPC

Neoplasm of ear

33.4

8.1

B02AA02

ATC

tranexamic acid; systemic

1.4

8.1

389

2852

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

17.2

8.1

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.6

8.1

225

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

22.0

8.0

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

2.8

8.0

172

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

7.9

1101

9371

R42

ICD-10 Finland

Dizziness and giddiness

1.3

7.9

736

5967

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.0

7.9

452

SFA00

NOMESCO Finland

Small filling

1.4

7.9

368

2681

C05AA08

ATC

fluocortolone; rectal, topical

1.4

7.9

444

3341

4056

NOMESCO Finland

13.0

7.9

N03AX12

ATC

gabapentin; oral

1.4

7.9

473

3600

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

7.8

150

890

M03BX02

ATC

tizanidine; oral

1.2

7.8

1940

17528

L03AB05

ATC

interferon alfa-2b; parenteral

10.8

7.8

M25.5

ICD-10 Finland

Pain in joint

1.3

7.8

854

7072

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

7.8

591

4662

L03

ICPC

Low back symptom/complaint

1.3

7.7

731

5941

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

45.1

7.7

QAE35

NOMESCO Finland

Repair of skin defect in head or neck after surgery or injury

45.1

7.7

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

45.1

7.7

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

45.1

7.7

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

7.7

294

2063

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.4

7.7

D07AC01

ATC

betamethasone; topical

1.2

7.7

1078

9185

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

3.3

7.6

110

C03CA01

ATC

furosemide; systemic

1.2

7.6

1016

8610

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

7.6

227

1512

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

8.8

7.5

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

6.2

7.5

EMB10

NOMESCO Finland

Tonsillectomy

1.8

7.5

124

702

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

7.5

216

1423

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

4.6

7.5

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.2

7.5

112

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.4

1704

15248

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

3.8

7.4

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

80.2

7.4

XX1AD

NOMESCO Finland

Other CT-examination

80.2

7.4

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

80.2

7.4

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

7.4

272

1896

TJF80

NOMESCO Finland

Ostomy education

6.5

7.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

7.4

312

2232

C10AA03

ATC

pravastatin; oral

1.5

7.4

238

1612

SPAT1360

SPAT

Extensive global examination

1.5

7.3

251

1720

R05FB02

ATC

cough suppressants and expectorants

1.2

7.3

1249

10848

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

7.3

340

2478

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

7.3

335

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

4.3

7.3

ENA10

NOMESCO Finland

Biopsy of pharynx

8.4

7.3

D10.09

ICD-10 Finland

Benign tumor of the lip UNS

8.4

7.3

2163D

ICD-9 Finland

Benign neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON BEN KASVAIN,MUU EPIDERM JA KARVAFOLL]

+∞

7.3

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

7.3

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

7.3

1CD02

NOMESCO Finland

+∞

7.3

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

7.3

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

7.3

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

7.3

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

7.3

2163F

ICD-9 Finland

Benign neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON BEN KASVAIN,TALIRAUH KASV]

+∞

7.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

7.3

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

7.3

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

7.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

7.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

7.3

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

7.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

7.3

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

7.3

1523

Kela drug reimbursment

+∞

7.3

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

7.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

7.3

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

7.3

1850A

ICD-9 Finland

Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]

+∞

7.3

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

7.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

7.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

7.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

7.3

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

7.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

7.3

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

+∞

7.3

C44.12

ICD-10 Finland

Spinocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

7.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

7.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

7.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

7.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

3054

Kela drug reimbursment

+∞

7.3

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

7.3

192

1239

ZZR10

NOMESCO Finland

Flap of skin and muscle

10.9

7.3

9734

FHL

Excision and local plastic or associated free skin grafting

4.1

7.3

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

9.4

7.3

205

Kela drug reimbursment

Chronic hypertension

1.2

7.3

995

8444

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

7.2

234

1587

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.9

7.2

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.9

7.2

147

K07.60

ICD-10 Finland

Snapping jaw

1.8

7.2

127

735

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

15.8

7.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

7.2

266

N05CF02

ATC

zolpidem; oral

1.3

7.2

489

3792

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

7.2

401

3017

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

7.2

1433

12645

TEA00

NOMESCO Finland

Biopsy of lip

3.3

7.1

105

JFB30

NOMESCO Finland

Right hemicolectomy

3.9

7.1

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.6

7.1

192

1246

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

7.1

267

1864

L73.8

ICD-10 Finland

Other specified follicular disorders

3.7

7.1

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.2

7.1

312

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

7.1

124

714

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

7.0

365

2712

R49.09

ICD-10 Finland

Unspecified dysphonia

3.0

7.0

123

M54.5

ICD-10 Finland

Low back pain

1.2

7.0

1000

8522

V03AE02

ATC

sevelamer; oral

4.4

6.9

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.9

811

6755

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

6.9

724

5947

JAL30

NOMESCO Finland

Omentectomy

6.3

6.9

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

6.9

202

GDC00

NOMESCO Finland

Lobectomy of lung

13.8

6.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

6.9

609

4901

B05DA

ATC

Isotonic solutions

3.9

6.8

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.0

6.8

L85.80

ICD-10 Finland

Hudhorn

5.0

6.8

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.1

6.8

EAA30

NOMESCO Finland

Partial excision of lower lip

40.1

6.8

L04AX02

ATC

thalidomide; oral

40.1

6.8

ZZS10

NOMESCO Finland

Transposition flap

40.1

6.8

4611

FHL

Facial tumor removal and possible reconstruction (multitose)

40.1

6.8

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

6.8

283

2023

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.7

6.7

143

874

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

16.7

6.7

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.7

6.7

136

819

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

6.7

471

3673

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

6.7

747

6184

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

6.7

348

R03AC02

ATC

salbutamol; inhalant

1.2

6.7

1682

15135

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

6.7

120

699

EDB00

NOMESCO Finland

Partial excision of mandible

22.5

6.7

N07CA01

ATC

betahistine; oral

1.5

6.6

234

1617

H60.8

ICD-10 Finland

Other otitis externa

2.1

6.6

364

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

6.6

414

3172

KC1GB

NOMESCO Finland

Cystography with X-ray

7.8

6.6

G44.2

ICD-10 Finland

Tension-type headache

1.4

6.6

379

2864

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

6.6

430

3313

H60.3

ICD-10 Finland

Other infective otitis externa

2.3

6.6

264

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

6.6

133

802

TK800

NOMESCO Finland

Hemodialysis

2.2

6.6

297

Z00.0

ICD-10 Finland

General medical examination

1.3

6.5

548

4377

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

6.5

3080

29311

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

6.5

122

719

8113

FHL

Fractional scraping

1.5

6.5

193

1286

A03FA02

ATC

cisapride; oral, rectal

1.4

6.5

256

1809

H93.1

ICD-10 Finland

Tinnitus

1.5

6.5

182

1197

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

6.4

399

-59

ICPC

Other therap proced/minor surg NEC

2.0

6.4

413

H26.4

ICD-10 Finland

After-cataract

1.4

6.4

299

2180

UJG02

NOMESCO Finland

Proctoscopy

2.3

6.4

249

N30.4

ICD-10 Finland

Irradiation cystitis

69.9

6.4

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

69.9

6.4

R05

ICD-10 Finland

Cough

1.3

6.4

572

4605

SPAT1138

SPAT

Guidance concerning bowel function

2.4

6.4

222

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

14.3

6.4

H05BX01

ATC

cinacalcet; oral

4.1

6.4

SPAT1053

SPAT

Memory test

1.3

6.4

524

4174

JN6AD

NOMESCO Finland

CT of torso and neck

4.9

6.3

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

6.3

257

1829

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

2.8

6.3

138

KED22

NOMESCO Finland

Transurethral resection of prostate

1.6

6.3

155

985

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.9

6.3

466

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

6.3

273

1963

M79.6

ICD-10 Finland

Pain in limb

1.2

6.3

1103

9577

M04AA01

ATC

allopurinol; systemic

1.3

6.3

385

2936

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

6.3

304

2233

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

5.9

6.3

L04AX01

ATC

azathioprine; systemic

1.7

6.3

122

730

J01MA14

ATC

moxifloxacin; systemic

1.5

6.3

238

1670

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

9.3

6.3

BAA60

NOMESCO Finland

Total thyroidectomy

2.3

6.3

226

C43

ICD-10 Finland

Malignant melanoma of skin

18.0

6.3

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.2

6.3

279

A04

ICPC

Weakness/tiredness general

1.3

6.3

393

3012

C44.4

ICD-10 Finland

Malignant neoplasm: Skin of scalp and neck

+∞

6.2

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

6.2

C44.2

ICD-10 Finland

Malignant neoplasm: Skin of ear and external auricular canal

+∞

6.2

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

6.2

189

Kela drug reimbursment

Imatinib

+∞

6.2

329

Kela drug reimbursment

Lenalidomide

+∞

6.2

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

+∞

6.2

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

6.2

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

6.2

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

6.2

Q85.1

ICD-10 Finland

Tuberous sclerosis

+∞

6.2

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

6.2

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

6.2

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

6.2

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

6.2

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

+∞

6.2

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

+∞

6.2

8094/3-C44.3

ICD-O-3

Basosquamous carcinoma of skin of other and unspecified parts of face

+∞

6.2

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

6.2

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

6.2

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

+∞

6.2

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

6.2

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

6.2

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.2

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

+∞

6.2

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

6.2

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.2

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

6.2

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

+∞

6.2

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

6.2

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.2

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.7

6.2

146

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

6.2

133

816

SPAT1125

SPAT

Stoma care and guidance

2.5

6.2

182

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

6.2

277

2005

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

6.2

281

2039

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

6.2

815

6871

SPAT1266

SPAT

Separate instruction to prepare for procedure

1.9

6.2

462

104

Kela drug reimbursment

Thyroid insufficiency

1.5

6.2

208

1424

JFF23

NOMESCO Finland

Transversostomy

6.3

6.2

H02.3

ICD-10 Finland

Blepharochalasis

1.5

6.1

193

1303

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

5.3

6.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.8

6.1

129

M01AE02

ATC

naproxen; oral, rectal

1.2

6.1

1792

16294

A02BC01

ATC

omeprazole; systemic

1.2

6.1

893

7612

L17

ICPC

Foot/toe symptom/complaint

1.2

6.1

766

6423

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

6.1

223

D17.0

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

2.2

6.1

243

S01

ICPC

Pain/tenderness of skin

1.7

6.1

120

722

ZXA10

NOMESCO Finland

Bilateral

1.3

6.1

574

4655

M02AA07

ATC

piroxicam; topical

1.2

6.1

1194

10478

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.7

6.1

113

669

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.8

6.1

130

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

6.1

141

884

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.8

6.0

538

WF099

NOMESCO Finland

Other radiotherapy

8.6

6.0

D22

ICD-10 Finland

Melanocytic naevi

1.8

6.0

100

571

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

6.0

300

2214

SPAT1285

SPAT

Provision of consultation response

1.5

6.0

169

1113

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

2269

11262

3.08

291.59

3.0

1.7

—

(3002256) Pathology report gross observation

749

2662

3.18

160.73

1.7

1.1

—

(4035726)

409

987

4.46

155.17

1.5

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

499

1771

3.05

105.05

3.7

1.4

24.0

11.1

ug/l

0.44

412

1307

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2254

16229

1.79

76.64

6.4

3.7

11.4

11.7

umol/l

0.35

2104

15107

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3172

25728

1.82

67.56

8.6

5.4

77.6

76.1

u/l

1.15

2955

23732

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2015

14614

1.70

61.97

4.4

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2359

18250

1.63

53.26

9.3

6.4

4.1

4.3

e9/l

3.56

2110

15640

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2217

16915

1.62

52.80

7.9

5.5

1.2

mmol/l

2.11

1865

14166

(3037467) Urinalysis macro (dipstick) panel - Urine

2919

24086

1.62

48.18

5.5

4.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1887

14068

1.59

47.83

5.5

3.7

35.6

g/l

0.10

1705

12803

(3013707) Erythrocyte sedimentation rate by Westergren method

3099

26012

1.64

47.10

4.7

4.1

12.9

12.3

mm/h

1.34

2838

23937

(3013826) Glucose [Moles/volume] in Serum or Plasma

2522

20172

1.58

46.82

4.9

4.2

6.7

6.8

mmol/l

2.12

2333

18701

(1761482) Bacteria [#/volume] in Urine by Culture

252

950

2.75

46.60

5.5

4.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1499

10637

1.62

46.30

2.9

2.3

57.9

58.9

u/l

0.21

1358

9715

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3864

34561

1.93

45.67

17.8

13.0

23.2

mg/l

0.02

3151

26987

(3044640) Blood type and Crossmatch panel - Blood

1365

9560

1.62

44.00

2.6

2.1

—

(3013115) Eosinophils [#/volume] in Blood

2198

17187

1.55

43.89

6.3

5.5

0.2

e9/l

3.06

1947

14965

(3001604) Monocytes [#/volume] in Blood

2119

16509

1.54

42.50

6.2

5.4

0.6

e9/l

0.57

1889

14146

(3006315) Basophils [#/volume] in Blood

2129

16617

1.54

42.26

6.2

5.4

0.0

e9/l

1.75

1898

14242

(3032080) INR in Blood by Coagulation assay

1817

13752

1.54

41.15

10.3

10.1

1.3

inr

1.20

383

3911

(3019198) Lymphocytes [#/volume] in Blood

2163

17005

1.53

41.09

6.2

5.4

1.9

e9/l

0.75

1943

14826

(3013512) EKG study

1424

10333

1.56

38.28

5.0

4.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

11.56

37.81

6.3

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

560

3201

1.86

37.05

4.7

2.8

243.5

237.0

u/l

0.38

517

2959

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1810

13937

1.51

36.43

4.2

3.8

34.9

77.8

ng/l

2.06

1334

9720

(3033705) Calcium.ionized [Moles/volume] in Venous blood

139

441

3.22

34.93

2.7

2.2

—

(42870588) Differential panel, method unspecified - Blood

1472

10956

1.51

34.33

6.5

5.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

104

5.93

34.27

34.0

23.1

116.3

115.4

ug/l

0.03

(3027273) Bicarbonate [Moles/volume] in Venous blood

349

1754

2.07

33.50

4.3

3.0

25.3

mmol/l

0.02

341

1687

(3002030) Lymphocytes/100 leukocytes in Blood

1992

15827

1.47

33.29

6.8

5.7

27.8

27.7

0.14

1819

14526

(3006504) Eosinophils/100 leukocytes in Blood

1938

15337

1.47

32.94

6.5

5.6

2.8

2.9

1.48

1773

14084

(3019069) Monocytes/100 leukocytes in Blood

1946

15425

1.47

32.73

6.9

5.9

8.6

0.14

1786

14236

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1922

15203

1.47

32.65

6.7

5.1

1.2

mmol/l

2.05

1673

13439

(3022096) Basophils/100 leukocytes in Blood

1885

14879

1.46

32.24

6.7

5.6

0.7

0.70

1718

13678

(3015377) Calcium [Moles/volume] in Serum or Plasma

1446

10850

1.49

31.87

3.5

2.0

2.4

mmol/l

0.07

1167

9047

(3023368) Bacteria identified in Blood by Culture

1201

8698

1.52

31.27

4.3

3.8

—

(3026008) Bacteria identified in Urine by Culture

1447

10909

1.48

30.94

3.7

3.2

—

(3019225) pH of Specimen

569

3443

1.75

30.80

4.7

3.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1959

15692

1.45

30.40

6.3

5.5

57.4

57.6

0.31

1786

14479

(40768793) Breast Pathology biopsy report

231

3.91

30.34

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

4114

38500

1.97

29.43

26.3

19.0

249.3

249.2

e9/l

0.01

4023

37317

(3024731) MCV [Entitic volume]

4115

38514

1.97

29.40

26.2

19.0

91.3

91.2

0.67

4045

37809

(3026361) Erythrocytes [#/volume] in Blood

4115

38521

1.97

29.28

26.3

19.0

4.4

4.5

e12/l

10.42

4011

37205

(3010813) Leukocytes [#/volume] in Blood

4115

38528

1.96

29.15

26.4

19.0

6.8

6.7

e9/l

1.26

4015

37207

(3030981) Hyaline casts [#/volume] in Urine by Automated count

332

1722

2.00

29.15

3.3

2.5

0.2

0.3

e6/l

1.60

327

1673

(40761511) CBC panel - Blood by Automated count

3907

36019

1.72

29.13

17.9

12.6

—

(3035941) MCH [Entitic mass]

4114

38517

1.96

29.13

26.2

18.9

30.4

30.3

0.40

4045

37811

(3000963) Hemoglobin [Mass/volume] in Blood

4115

38532

1.96

29.08

26.4

19.1

133.3

135.1

g/l

12.87

4046

37829

(3019550) Sodium [Moles/volume] in Serum or Plasma

3909

36054

1.72

28.95

20.4

15.5

139.7

mmol/l

0.15

3809

35011

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2564

21687

1.43

28.94

3.4

2.9

50.3

44.7

u/l

2.00

2324

19909

(3023103) Potassium [Moles/volume] in Serum or Plasma

3914

36155

1.71

28.27

20.6

15.6

4.0

mmol/l

1.20

3807

35046

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3975

36884

1.76

28.13

12.2

9.0

24.5

24.9

u/l

0.90

3811

35241

(3000330) Specific gravity of Urine by Test strip

351

1888

1.93

27.71

5.2

3.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2686

23034

1.42

27.25

5.5

4.5

1423.2

2887.6

e6/l

0.83

330

(3004119) Hemoglobin [Mass/volume] in Venous blood

389

2180

1.86

27.06

3.9

3.1

128.0

129.9

g/l

1.01

381

2114

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3961

36844

1.71

26.13

20.3

14.8

81.2

78.0

umol/l

5.32

3961

36830

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

125

444

2.87

25.87

9.4

5.2

402.0

476.4

iu/ml

0.18

(3004809) Band form neutrophils/100 leukocytes in Blood

113

382

3.01

25.56

3.6

2.8

1.2

0.07

282

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

159

646

2.52

25.28

3.2

1.8

906.2

77.0

u/ml

0.56

138

510

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1415

10942

1.43

25.27

3.3

3.1

1694.5

1541.9

ng/l

0.45

1201

9377

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1801

14575

1.40

24.61

2.5

2.2

78.3

78.4

nmol/l

0.01

1569

12854

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1003

7303

1.48

24.46

2.5

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3433

31057

1.47

24.14

18.1

14.2

38.0

39.4

8.17

1997

21196

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3557

32457

1.49

23.45

5.5

4.8

2.0

2.1

mu/l

0.52

3194

29556

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1336

10339

1.42

23.35

3.7

2.6

32.9

34.4

u/l

0.23

1256

9721

(3007853) Bacteria identified in Skin by Aerobe culture

593

3884

1.61

23.35

1.9

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3058

27172

1.41

23.03

4.5

4.0

15.0

14.8

pmol/l

2.13

2707

24541

(3002032) Base excess in Venous blood by calculation

503

3189

1.65

22.54

4.3

3.5

2.1

2.0

mmol/l

0.36

414

2590

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

241

1226

2.02

22.29

1.9

1.8

1.3

1.8

ug/l

0.67

202

1045

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

295

1622

1.88

21.71

2.8

2.6

0.7

0.95

284

1555

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

676

4639

1.54

21.61

9.2

7.1

—

(3042936) Bacteria identified in Isolate by Culture

651

4443

1.55

21.32

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

13.39

21.09

1.1

1.0

1.1

1.6

ug/l

—

(40768443) Skin Pathology biopsy report

253

1342

1.94

20.76

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

430

2681

1.67

20.49

3.6

2.9

4.4

4.5

kpa

0.27

424

2578

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

434

2716

1.66

20.38

4.5

3.6

105.5

91.1

ng/l

1.34

354

2276

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3693

34203

1.48

20.19

5.5

4.7

6.0

mmol/l

0.34

3328

31006

(3007930) Methemoglobin/Hemoglobin.total in Blood

262

1427

1.89

19.85

4.4

5.0

0.9

0.01

248

1335

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

378

2300

1.70

19.72

1.6

—

(3006462) Nitrate [Presence] in Urine

170

3.68

19.65

4.1

3.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

491

3202

1.60

19.51

4.3

3.5

5.7

5.8

kpa

2.62

484

3091

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

262

1441

1.87

19.26

4.3

4.9

1.5

1.6

1.19

248

1347

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

640

4458

1.51

18.90

4.6

4.7

33.2

33.1

0.09

371

2971

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

997

7561

1.41

18.84

1.7

1.1

1.2

mg/l

0.26

742

5735

(3003458) Phosphate [Moles/volume] in Serum or Plasma

599

4120

1.52

18.77

8.0

5.1

1.0

mmol/l

0.12

548

3762

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

759

5482

1.46

18.70

1.9

1.8

—

(3000494) Fungus identified in Specimen by Culture

562

3827

1.54

18.43

1.6

1.4

—

(40768795) Lymph node Pathology biopsy report

5.50

18.35

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3685

34267

1.45

18.27

5.0

4.5

1.5

mmol/l

0.89

3333

31412

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3577

33086

1.42

18.24

4.5

4.0

1.3

mmol/l

0.06

3206

30065

(3009261) Glucose [Presence] in Urine by Test strip

2047

17430

1.32

18.16

4.8

3.8

0.0

estimate

1.32

267

2906

(3019309) Folate [Moles/volume] in Red Blood Cells

975

7410

1.40

18.10

1.8

1122.0

1167.0

nmol/l

0.74

724

5563

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3532

32611

1.41

18.07

6.9

6.0

40.0

40.2

mmol/mol

0.67

3205

30033

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3707

34535

1.45

17.96

5.0

4.5

4.6

mmol/l

1.75

3376

31863

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

328

2.78

17.86

4.6

2.6

2393.4

573.1

u/ml

—

(40760892) CBC W Ordered Manual Differential panel - Blood

938

7098

1.41

17.82

4.8

4.0

—

(4211845)

190

3.35

17.33

4.0

3.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1152

9070

1.37

17.10

2.4

2.3

3.0

2.9

mg/l

0.78

968

7667

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

246

1380

1.83

16.99

2.0

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1155

9110

1.36

16.92

3.2

2.4

5747.9

5346.7

umol/l

0.10

979

7725

(3012095) Magnesium [Moles/volume] in Serum or Plasma

664

4765

1.46

16.77

3.7

2.5

0.8

mmol/l

1.96

608

4337

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

232

1285

1.85

16.69

1.9

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

6.46

16.63

1.4

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1299

10473

1.34

16.37

5.7

3.9

4.4

2.5

ug/l

1.25

1144

9359

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1758

14798

1.31

16.35

3.1

2.8

141.3

116.5

ug/l

3.08

1585

13579

(3027945) Reticulocytes/100 erythrocytes in Blood

553

3846

1.50

16.32

2.6

2.2

1.8

1.7

0.22

468

3339

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3762

35282

1.44

16.28

5.5

5.1

2.7

mmol/l

0.64

3409

32390

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

320

1962

1.68

16.19

2.4

2.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1384

11288

1.33

16.04

2.2

2.1

172.0

207.7

u/l

1.33

1286

10513

(3049717) Cytology report of Urine Cyto stain

191

1012

1.93

15.76

2.6

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

218

1217

1.83

15.31

2.6

1.5

43.4

26.2

u/ml

0.78

210

1154

(3014576) Chloride [Moles/volume] in Serum or Plasma

557

3964

1.46

14.56

5.6

6.1

104.4

104.2

mmol/l

0.49

540

3868

(40768800) Prostate Pathology biopsy report

176

3.21

14.47

1.2

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1986

17190

1.28

14.26

4.8

3.7

0.0

estimate

0.50

263

2953

(40761535) Cells panel - Urine sediment

446

3055

1.51

14.08

4.4

3.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

132

640

2.10

14.00

1.7

1.4

—

(3026782) Osmolality of Urine

837

6442

1.37

13.96

3.7

2.6

553.8

541.9

mosm/kgh2o

0.80

703

5350

(3023520) Reticulocytes [#/volume] in Blood

421

2855

1.52

13.93

2.9

2.2

69.0

68.7

e9/l

0.06

328

2162

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.21

13.86

2.2

2.4

—

(3037756) Immunofixation for Serum or Plasma

127

613

2.10

13.64

1.7

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

737

5595

1.38

13.32

2.9

2.6

1.2

e6/l

0.20

492

3204

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

127

621

2.08

13.19

1.8

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

1979

17239

1.27

13.07

6.7

5.0

0.0

estimate

0.80

269

3000

(3020630) Protein [Mass/volume] in Serum or Plasma

401

2729

1.52

13.04

2.9

1.6

66.0

66.6

g/l

0.82

349

2410

(3022313) Gas panel - Capillary blood

249

1521

1.68

12.79

4.1

3.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1571

13333

1.28

12.78

5.2

4.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

316

2051

1.58

12.71

3.9

3.4

1.3

1.9

mmol/l

1.82

213

1498

(3017354) Segmented neutrophils/100 leukocytes in Blood

263

2.65

12.67

3.9

2.7

56.9

59.5

0.29

163

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

130

3.41

12.58

6.2

1.1

46.6

119.3

u/ml

0.74

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

181

1022

1.80

12.30

3.3

2.8

—

(3018418) pH of Serum or Plasma

1195

9855

1.29

12.06

5.3

3.2

7.4

0.11

187

1693

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

219

1321

1.69

11.81

4.3

3.8

24.6

24.9

mmol/l

0.70

199

1196

(3009343) pH of Capillary blood

321

2127

1.55

11.80

3.9

3.5

7.4

0.73

262

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

325

2160

1.54

11.79

3.9

3.5

5.1

5.2

kpa

2.52

292

1973

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

18.96

11.57

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

642

4883

1.37

11.34

2.8

2.5

2.3

g/l

0.49

569

4467

(3020779) Urea [Moles/volume] in Serum or Plasma

399

2801

1.47

11.12

10.6

6.7

10.9

10.7

mmol/l

0.22

370

2644

(3017181) Myelocytes/100 leukocytes in Blood

370

2560

1.49

11.09

3.8

3.7

0.9

0.7

0.68

132

528

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1763

15364

1.25

10.93

2.2

2.0

94.6

95.4

pmol/l

0.30

905

7796

(3048689) Calprotectin [Mass/mass] in Stool

537

3995

1.39

10.85

2.3

2.2

113.5

142.1

ug/g

1.49

420

3091

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

379

2.24

10.76

1.5

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

357

2469

1.49

10.72

3.8

0.1

0.21

127

495

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

257

2.51

10.64

2.5

2.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

357

2474

1.48

10.62

2.4

2.0

0.2

g/l

1.49

326

2229

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

992

8112

1.29

10.46

1.8

1.7

71083218.5

35080224.4

pmol/l

0.57

785

6642

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

484

2.07

10.37

1.6

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

432

2.13

10.30

1.8

1.4

—

(3019150) Specific gravity of Urine by Refractometry

969

7923

1.29

10.19

5.1

4.2

1.0

kg/l

0.14

139

1207

(44806118)

319

2.31

10.10

1.8

1.4

—

(44790047)

319

2.31

10.10

1.8

1.4

—

(44790048)

319

2.31

10.10

1.8

1.4

—

(44790049)

319

2.31

10.10

1.8

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2247

20211

1.23

10.03

2.9

2.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

241

2.51

9.99

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

256

1678

1.56

9.90

2.5

2.2

11.7

13.9

nmol/l

4.68

219

1472

(3005719) IgG [Mass/volume] in Serum or Plasma

318

2185

1.49

9.87

2.7

2.2

9.7

10.7

g/l

4.77

285

1978

(3022621) pH of Urine by Test strip

349

2444

1.46

9.84

3.7

3.1

—

(3022145) Colonoscopy Study observation

459

3391

1.39

9.63

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.93

9.57

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

290

2.33

9.50

1.3

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

1186

10008

1.25

9.49

3.8

3.0

46.2

71.3

e6/l

1.25

953

7558

(3004588) Protein electrophoresis panel - Serum or Plasma

336

2354

1.46

9.46

2.8

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

316

2188

1.48

9.45

6.0

6.8

24.5

24.6

mmol/l

0.25

295

2028

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

454

2.05

9.43

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

9.38

1.0

0.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

679

5360

1.32

9.23

2.8

2.5

13.0

umol/l

0.04

612

4885

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

126

698

1.83

9.20

2.5

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

335

2360

1.45

9.17

3.7

3.6

0.9

0.5

0.55

399

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

459

3420

1.38

9.15

3.2

2.2

7.5

umol/l

0.01

392

2894

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

649

5099

1.32

9.12

3.1

2.8

2.6

3.1

e6/l

0.76

408

2723

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

289

1986

1.49

8.98

1.6

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

283

1939

1.49

8.92

3.1

3.0

4.4

4.5

pmol/l

1.21

255

1698

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

232

1526

1.55

8.86

2.4

1.6

1.5

g/l

0.10

181

1299

(3017732) Neutrophils [#/volume] in Blood

328

2319

1.45

8.81

2.9

4.2

4.1

e9/l

0.07

213

1729

(3003338) MCHC [Mass/volume]

3122

29228

1.23

8.78

22.8

16.9

331.9

332.0

g/l

0.26

3094

28960

(3047181) Lactate [Moles/volume] in Blood

173

1064

1.65

8.75

4.8

6.1

1.5

1.3

mmol/l

0.82

152

929

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

579

4506

1.33

8.68

2.9

2.6

23.0

22.6

0.30

456

3774

(3008757) Leukocyte morphology finding [Identifier] in Blood

277

2.29

8.65

4.5

3.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

157

945

1.69

8.62

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

407

3022

1.38

8.28

5.7

7.4

122.5

121.9

g/l

0.24

387

2901

(3036481) Cortisol [Moles/volume] in Serum or Plasma

395

2920

1.39

8.25

2.6

1.8

364.8

369.1

nmol/l

0.16

347

2637

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

217

2.41

8.05

1.5

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

217

2.41

8.05

1.5

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

217

2.41

8.05

1.5

1.3

—

(3014271) Vancomycin [Susceptibility]

195

2.48

7.88

3.3

3.0

—

(3003396) Base excess in Arterial blood by calculation

481

3698

1.34

7.82

5.4

6.7

1.2

1.3

mmol/l

0.33

372

2820

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

284

2.20

7.77

3.0

2.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

494

3822

1.33

7.69

1.8

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

286

2.18

7.64

2.1

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

255

2.25

7.57

1.7

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.61

7.54

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

437

1.94

7.51

1.5

1.3

—

(3039000) Anion gap in Blood

124

729

1.72

7.47

5.5

7.2

11.5

11.3

mmol/l

0.17

111

649

(3041096) Erythrocytes [Presence] in Urine by Automated

1060

9033

1.23

7.47

4.8

3.4

—

(3018572) Chloride [Moles/volume] in Blood

124

730

1.72

7.44

5.5

7.2

104.9

104.8

mmol/l

0.14

111

650

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3406

32359

1.23

7.42

15.8

11.8

76.7

78.1

ml/min/173m2

3.14

2806

26011

(3016502) Oxygen saturation in Arterial blood

436

3334

1.34

7.35

5.4

7.0

95.6

95.2

0.61

417

3191

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

492

3833

1.32

7.29

1.9

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

128

765

1.69

7.28

3.2

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

479

3723

1.32

7.22

5.4

6.7

11.9

11.7

kpa

0.36

454

3517

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

479

3724

1.32

7.20

5.4

6.7

5.0

5.1

kpa

0.31

455

3526

(40768797) Stomach Pathology biopsy report

585

4680

1.29

7.11

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

363

2.00

7.06

2.8

1.9

135.7

90.2

u/ml

0.27

331

(3018095) Leukocytes [#/volume] in Urine

1355

11884

1.20

7.05

4.3

3.5

99.6

107.4

e6/l

0.18

1035

8224

(3030467) Casts [#/volume] in Urine by Automated count

1071

9192

1.22

6.97

3.6

2.9

0.4

e6/l

0.07

845

6837

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

372

1.98

6.96

5.6

6.7

11.7

12.2

mg/l

0.43

340

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

162

1040

1.58

6.95

3.6

1.6

36.7

39.6

mg/l

0.16

134

847

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

171

2.47

6.91

2.4

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

429

1.90

6.90

2.3

2.1

29.8

23.6

mg/l

0.29

105

(3019060) Gas panel - Arterial blood

309

2262

1.39

6.87

4.5

4.8

—

(3011412) CD3 cells [#/volume] in Blood

190

2.38

6.85

1.9

2.3

1.2

1.1

e9/l

0.41

113

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.18

6.83

1.8

1.3

—

(3048879) Bone marrow aspiration report

3.35

6.82

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

622

5041

1.27

6.81

29.2

28.3

1.4

inr

0.17

705

(3013139) Helicobacter pylori Ag [Presence] in Stool

321

2370

1.38

6.78

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

441

3418

1.32

6.78

2.6

2.4

6.0

7.0

ug/l

0.38

353

2927

(3037121) Protein [Mass/volume] in Urine

166

1080

1.56

6.73

3.2

2.6

0.4

0.3

g/l

0.24

362

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

882

7445

1.23

6.73

1.3

2.0

1.8

u/ml

0.17

216

1955

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

158

1018

1.57

6.69

1.4

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

169

2.44

6.58

1.2

1.3

9.9

10.4

u/l

0.14

150

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

118

710

1.68

6.58

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

628

5121

1.26

6.52

2.0

1.9

29.3

29.9

1.77

604

4943

(3037522) Nuclear Ab [Titer] in Serum

572

4613

1.28

6.51

1.3

642.6

522.0

titre

0.58

123

1022

(3034860) Kappa light chains.free [Mass/volume] in Serum

160

1042

1.56

6.48

3.6

1.6

74.7

45.6

mg/l

0.58

133

854

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

990

8485

1.21

6.47

5.1

3.7

22.3

24.2

3.58

513

4093

(3024522) Salmonella sp identified in Specimen by Organism specific culture

389

1.92

6.47

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1311

11537

1.19

6.46

4.4

3.9

9.5

8.5

mg/mmol

0.25

797

7211

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

376

1.93

6.42

1.8

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

731

6083

1.24

6.34

1.3

28.1

34.1

iu/ml

0.73

196

1892

(3000570) Elastase.pancreatic [Mass/mass] in Stool

147

944

1.58

6.33

1.6

1.4

246.4

295.7

ug/g

2.37

562

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

700

5799

1.25

6.33

1.3

8.9

12.6

u/ml

0.86

250

2212

(3025941) Bacteria identified in Stool by Culture

256

1843

1.41

6.29

1.4

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

386

1.91

6.29

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

114

2.73

6.26

1.5

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

114

2.73

6.26

1.5

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

114

2.73

6.26

1.5

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

114

2.73

6.26

1.5

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

510

1.78

6.23

1.5

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

231

2.18

6.21

1.2

1.3

304.8

271.0

u/l

0.25

219

(3021960) Folate [Moles/volume] in Serum or Plasma

1007

8685

1.21

6.13

1.6

1.5

20.6

nmol/l

0.01

825

7343

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

397

1.88

6.11

1.3

—

(3025159) Blasts/100 leukocytes in Blood

315

2360

1.36

6.09

3.8

3.9

0.1

0.3

0.47

430

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

455

1.82

6.09

1.5

1.4

120.4

106.6

u/ml

0.78

(3017704) Immunofixation for Urine

182

2.32

6.07

1.4

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

283

2.03

5.90

1.7

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.01

5.89

4.9

4.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

280

2073

1.37

5.85

1.3

150.8

229.4

u/ml

1.98

260

1914

(3028026) IgM [Mass/volume] in Serum or Plasma

241

1741

1.41

5.83

1.8

1.4

1.3

1.2

g/l

0.27

209

1573

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

186

2.27

5.79

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

287

2.00

5.69

1.8

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.97

5.67

1.7

1.5

—

(3042733) HLA Ab [Presence] in Serum

2.97

5.67

4.6

5.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.94

5.56

1.7

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.94

5.56

1.7

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

367

1.87

5.55

1.5

1.3

—

(40768806) Pleura Pathology biopsy report

244

2.06

5.45

1.4

1.6

—

(40758558) Short blood count panel - Blood

894

7703

1.20

5.43

7.5

4.7

—

(3000850) Epithelial cells [#/volume] in Urine

821

7018

1.21

5.43

3.2

2.4

4.2

5.6

e6/l

4.13

726

6054

(3004616) Nuclear Ab [Presence] in Serum

451

1.77

5.39

1.5

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

167

2.29

5.36

1.2

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

2.98

5.25

1.5

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

382

1.82

5.22

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

125

811

1.56

5.22

1.9

2.0

12.2

11.3

mg/l

0.52

111

741

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

546

1.68

5.21

4.1

3.5

58.3

58.0

0.08

546

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

347

2702

1.31

5.19

4.6

2.9

1.2

mmol/l

0.09

309

2249

(3003434) Protein [Mass/volume] in Pleural fluid

354

1.85

5.18

1.4

1.5

32.4

28.2

g/l

1.86

309

(40768441) Liver Pathology biopsy report

145

2.36

5.14

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

964

8402

1.19

5.13

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

481

1.72

5.11

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

388

3073

1.29

5.11

1.9

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.73

5.09

1.5

1.3

54.3

63.8

0.58

(3023383) Lactate [Moles/volume] in Pleural fluid

3.01

5.09

1.3

1.4

3.3

3.1

mmol/l

0.08

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

348

2719

1.30

5.08

2.7

2.3

62.1

64.3

ml/min/173m2

0.53

150

1067

(4010399)

329

2552

1.31

5.06

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

619

5188

1.22

4.98

1.7

1.5

—

(3028433) Virus identified in Specimen by Culture

106

2.56

4.87

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

221

1625

1.38

4.86

7.0

9.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

384

1.78

4.85

1.4

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

189

1354

1.41

4.85

2.0

1.9

36.7

38.9

u/l

0.81

164

1172

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

137

2.35

4.82

2.2

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

125

827

1.53

4.81

1.5

1.3

229.0

221.8

miu/ml

0.08

382

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.79

4.81

1.6

2.4

—

(3033658) Prothrombin time (PT) actual/Normal

892

7768

1.19

4.76

4.2

3.4

89.5

88.0

0.97

867

7542

(3043409) Potassium [Moles/volume] in Arterial blood

152

1050

1.46

4.75

3.8

4.2

3.9

mmol/l

0.17

141

984

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

279

1.91

4.72

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

108

2.51

4.70

2.2

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

381

1.77

4.68

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

568

4754

1.22

4.63

1.9

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1257

1.42

4.61

3.5

1.4

9.7

10.3

g/l

0.99

134

1037

(3044927) Protein electrophoresis panel - Urine

401

1.73

4.49

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

3.42

4.46

1.1

1.0

—

(3036603) Volume of Urine

188

2.08

4.45

1.6

1.4

2067.1

1913.1

0.22

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

482

3987

1.23

4.40

1.8

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

142

984

1.46

4.39

3.4

3.3

0.4

0.3

u/ml

0.12

574

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.01

4.39

1.5

1.1

—

(3004775) Volume in Urine collected for unspecified duration

273

1.88

4.35

2.5

2.4

872.2

620.4

2.38

177

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

143

995

1.45

4.34

1.9

1.6

1.2

g/l

0.04

135

933

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

264

2032

1.32

4.33

1.6

1.7

—

(3000991) Gas panel - Venous blood

327

2596

1.28

4.26

6.0

7.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.04

4.23

2.0

2.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

146

2.20

4.20

2.0

2.1

12.6

14.8

0.26

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1350

1.38

4.15

3.5

1.4

7.4

7.5

g/l

0.20

106

983

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

112

750

1.51

4.13

4.8

2.8

1.8

1.6

mg/l

0.70

662

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.54

4.12

3.0

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

183

1346

1.38

4.07

3.5

1.4

3.8

g/l

0.27

100

941

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

183

1348

1.37

4.04

3.5

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

492

1.62

4.01

1.2

—

(44806420)

111

2.35

3.99

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

143

2.18

3.98

1.8

2.2

524.6

457.2

e6/l

0.33

126

(3007164) IgA [Mass/volume] in Serum or Plasma

723

6277

1.18

3.96

1.5

1.3

2.5

2.4

g/l

0.08

413

3647

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

269

2107

1.29

3.91

1.4

1.3

45.4

50.1

au/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

598

1.55

3.91

1.7

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.43

3.90

2.0

2.2

—

(3045142) Bone marrow Pathology biopsy report

227

1.90

3.86

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.19

3.77

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.65

3.72

2.2

2.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

291

2318

1.27

3.72

2.6

2.4

28.5

25.0

au/ml

0.11

114

(3051651) Icteric interference index of Serum or Plasma

154

2.09

3.72

5.7

4.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

155

2.07

3.66

2.2

44.2

47.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

648

1.51

3.66

1.6

1.3

11.3

10.5

u/l

0.21

532

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.61

3.63

1.3

1.4

0.9

2.1

1.12

(3014111) Lactate [Moles/volume] in Serum or Plasma

347

2831

1.24

3.62

4.7

6.1

1.4

mmol/l

0.04

340

2712

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

123

864

1.44

3.61

1.8

2.1

4350.3

4415.8

u/l

0.01

368

(3009508) Creatinine [Moles/volume] in Urine

1257

11444

1.14

3.59

3.5

3.1

7.1

7.3

mmol/l

0.77

1014

9574

(3012516) Albumin [Mass/volume] in Urine

1202

10913

1.14

3.58

3.6

3.2

711.4

293.4

mg/l

1.51

740

6804

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.51

3.54

1.2

2.2

209.2

123215.0

u/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

286

1.76

3.51

1.5

1.6

51129.9

56076.5

e6/l

0.06

170

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

703

6150

1.17

3.50

3.1

2.2

2.5

2.4

mmol/l

0.40

591

5263

(3035880) pH of Pleural fluid

138

2.11

3.48

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.34

3.47

2.1

2.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

135

972

1.40

3.47

1.9

1.6

0.2

g/l

0.59

127

914

(3021901) Oxygen saturation in Capillary blood

616

1.50

3.45

2.5

2.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

497

1.56

3.42

1.3

1.2

307.6

262.5

u/ml

0.67

307

(3023199) Leukocytes [#/volume] in Pleural fluid

319

1.70

3.40

1.4

1.6

988.9

2697.4

e6/l

1.46

230

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

396

3302

1.22

3.38

3.0

207.7

219.5

ng/l

0.18

357

3022

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

174

1.96

3.38

2.6

2.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.25

3.34

1.0

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

156

1159

1.36

3.33

1.5

1.7

77.9

318.0

titre

—

(3002385) Erythrocyte distribution width [Ratio]

2941

28234

1.12

3.32

20.7

15.4

13.8

13.7

3.24

2889

27486

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

216

1683

1.30

3.32

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

525

1.53

3.31

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

360

1.65

3.31

1.3

1.4

29.0

27.5

u/l

0.12

278

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

793

7034

1.16

3.29

4.0

3.9

241.6

432.7

ng/l

1.50

621

5597

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

142

2.05

3.25

2.4

2.2

657.0

802.8

e6/l

0.66

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.37

3.18

6.4

5.5

—

(3003181) Sodium [Moles/volume] in Urine

613

1.48

3.14

1.3

59.4

64.2

mmol/l

0.64

488

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

556

1.50

3.14

1.6

1.5

—

(3020891) Body temperature

183

1406

1.31

3.13

4.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

268

1.72

3.08

2.0

1.7

—

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

125

2.09

3.07

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

138

1020

1.36

3.07

1.9

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

10.01

2.98

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

126

924

1.37

2.95

2.8

2.3

100.3

103.6

ug/min

0.04

538

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

492

1.51

2.93

1.4

1.2

—

(3011985) Renin [Units/volume] in Plasma

436

1.54

2.92

1.3

1.4

28.9

54.3

mu/l

1.90

385

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

177

1.87

2.90

1.6

2.0

2.6

2.8

u/field

0.03

127

(3022493) Free Hemoglobin [Mass/volume] in Plasma

136

1.99

2.84

1.2

5.6

59.6

68.2

mg/l

0.31

(3020961) Endomysium IgA Ab [Titer] in Serum

194

1525

1.28

2.83

1.1

23.8

223.8

titre

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

110

796

1.39

2.81

2.4

3.3

3.6

g/l

1.79

101

747

(3020874) Milk IgE Ab [Units/volume] in Serum

151

1.93

2.79

1.0

0.6

2.4

u/ml

0.60

(3014765) Yersinia sp identified in Stool by Organism specific culture

132

987

1.35

2.76

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

411

1.54

2.74

1.5

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

103

741

1.40

2.73

2.5

2.9

8.3

7.9

kpa

1.19

682

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

181

1.83

2.73

1.2

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

286

1.65

2.72

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.37

2.72

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.43

2.70

1.9

2.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.98

2.69

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

267

2196

1.23

2.66

1.2

168.6

136.0

iu/ml

0.61

102

844

(3034274) Bile acid [Moles/volume] in Serum --fasting

327

1.60

2.65

1.7

1.9

8.5

5.9

umol/l

0.42

226

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

329

1.59

2.59

1.6

1.4

0.2

0.4

nmol/l

2.28

274

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.61

2.57

1.2

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

130

983

1.33

2.55

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

581

5135

1.15

2.54

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

617

1.42

2.53

2.4

2.7

31.9

34.6

umol/l

0.37

530

(42529406) Shigella sp [Presence] in Stool by Culture

131

995

1.33

2.50

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

302

1.60

2.46

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

116

869

1.34

2.44

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

150

1166

1.30

2.43

1.4

1.3

26.5

30.6

iu/l

0.85

130

1014

(3051387) C reactive protein [Mass/volume] in Capillary blood

109

809

1.36

2.43

3.8

3.7

27.4

27.6

mg/l

0.02

533

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

120

904

1.34

2.43

1.2

1.1

12.3

5.9

u/ml

0.82

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

319

1.57

2.43

3.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.17

2.40

1.1

0.3

1.9

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

117

1.97

2.40

3.6

2.4

42.7

44.2

—

(36304419) Bacteria [Presence] in Urine

971

8905

1.12

2.36

3.6

2.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

293

2465

1.20

2.36

1.9

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

4.12

2.36

3.7

3.8

205.4

396.1

u/l

—

(40758292) HTLV I+II Ab panel - Serum

4.12

2.36

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.26

2.34

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

113

850

1.34

2.33

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1019

9382

1.11

2.30

5.3

4.1

0.0

estimate

0.33

260

2933

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.38

2.29

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

912

8364

1.11

2.21

4.5

3.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

806

1.34

2.20

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

534

1.41

2.18

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

337

1.52

2.16

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

306

1.54

2.13

1.9

2.3

1.1

1.9

u/field

0.81

119

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

159

1.77

2.13

1.1

62.4

78.7

u/l

0.92

116

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

159

1.77

2.13

1.1

13.2

21.9

u/l

1.15

110

(3024471) HLA-A [Type]

2.10

2.12

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

2.37

2.12

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

404

1.47

2.11

1.2

1.3

—

nmol/l

—

(3047189) Immunofixation for 24 hour Urine

123

1.87

2.11

2.1

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

413

1.46

2.10

1.2

1.3

275.4

291.8

pmol/l

0.19

308

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.20

2.09

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

125

971

1.30

2.08

1.4

1.2

36.6

45.2

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

198

1.67

2.08

1.3

1.4

25.7

66.0

pmol/l

3.20

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

332

2859

1.17

2.08

2.5

2.2

48.3

52.8

u/l

0.09

275

2406

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.00

2.07

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

229

1914

1.21

2.02

1.6

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

139

1102

1.27

1.99

1.7

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

160

1292

1.25

1.97

1.7

1.6

—

(3023419) Bacteria identified in Sputum by Culture

444

1.42

1.97

2.9

2.5

—

(3008295) Osmolality of Serum or Plasma

329

1.49

1.95

1.3

1.4

280.5

277.3

mosm/kgh2o

0.53

245

(3036525) Urea [Moles/time] in 24 hour Urine

3.75

1.93

3.5

2.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.75

1.93

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

142

1.76

1.92

1.6

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

142

1.76

1.92

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

142

1.76

1.92

1.6

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.19

1.88

1.4

1.3

—

(4146454)

416

1.42

1.85

3.3

2.7

—

(3024932) HLA-DR beta [Type]

2.03

1.85

1.1

—

(3044889) 12 lead EKG panel

2521

24355

1.08

1.84

4.4

3.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

114

892

1.29

1.84

1.4

1.3

11.8

6.1

u/ml

0.33

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

167

1.68

1.83

1.6

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.50

1.83

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

113

884

1.29

1.83

2.9

3.1

24.3

25.0

mmol/l

1.27

776

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

115

902

1.28

1.82

1.4

1.3

3.8

5.2

u/ml

0.45

148

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.17

1.82

1.2

1.7

35.7

13.3

nmol/l

—

(3026726) Creatinine [Moles/volume] in Specimen

4.17

1.82

4.0

4.8

351.2

339.6

umol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

183

1.64

1.81

1.2

1.1

—

(4015189)

101

1.88

1.80

2.7

2.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.05

1.80

1.9

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

147

1192

1.24

1.77

2.0

2.2

356.9

719.2

ug/l

1.15

135

1115

(3052851) Hemolysis interference index of Serum or Plasma

119

942

1.27

1.76

3.7

3.5

—

(21494434) Karyotype in Bone marrow

240

1.55

1.75

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.98

1.74

2.0

1.3

—

(3012441) Differential panel - Pleural fluid

273

1.51

1.73

1.4

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.67

1.72

1.0

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.85

1.71

1.2

1.1

—

(3034426) Prothrombin time (PT)

103

1.85

1.71

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

148

1.69

1.70

1.0

0.5

1.6

u/ml

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

114

903

1.27

1.69

1.7

298.6

307.4

mu/l

0.14

104

817

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

204

1.57

1.65

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

531

1.34

1.61

1.7

1.5

—

(3042631) Mycobacterium sp identified in Specimen

386

1.40

1.61

2.7

3.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

353

1.42

1.60

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

315

2766

1.15

1.59

2.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.69

1.58

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.82

1.57

2.4

2.0

0.5

1.2

ug/l

3.02

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

457

1.36

1.55

1.3

0.1

0.3

nmol/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

500

1.35

1.55

1.2

1.1

12.7

12.2

au/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

816

1.27

1.55

1.7

1.8

5.1

4.5

iu/l

0.18

285

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

746

1.28

1.54

1.4

1.2

1.7

5.5

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

458

1.36

1.54

1.4

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

273

1.47

1.53

1.3

13.9

11.5

mmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

416

1.38

1.52

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

112

900

1.25

1.51

1.8

1.6

12193.9

12716.6

e6/l

0.05

655

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

161

1345

1.20

1.50

1.1

0.9

1.3

u/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

152

1263

1.21

1.50

3.8

1.4

3.0

3.1

g/l

0.51

102

963

(3015171) Extractable nuclear Ab [Units/volume] in Serum

164

1377

1.20

1.46

1.3

1.2

0.3

0.9

u/ml

1.49

132

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

203

1.53

1.45

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

117

1.71

1.44

1.1

1.3

—

(3045414) Leukocytes [Presence] in Urine

188

1600

1.18

1.44

2.0

1.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.82

1.41

1.1

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

118

1.70

1.41

1.5

1.1

40.4

39.3

g/l

0.13

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

197

1.53

1.40

1.1

1.0

10.2

12.8

iu/ml

0.27

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

197

1.53

1.40

1.7

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.94

1.38

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

106

859

1.24

1.35

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

248

1.46

1.35

1.2

—

(3016750) Collection duration of Urine

191

1.52

1.34

3.4

2.1

461.7

497.6

min

1.34

140

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

144

1.60

1.31

1.0

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.10

1.30

1.0

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

201

1.50

1.29

1.7

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.36

1.29

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.36

1.29

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.36

1.29

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

395

1.35

1.28

1.1

1.4

1.5

g/l

0.71

343

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

104

849

1.23

1.26

2.1

92.2

91.1

0.16

792

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

138

1.60

1.26

1.1

—

(3012565) Volume of 24 hour Urine

138

1.60

1.26

2.7

2.1

2022.7

1898.2

0.16

118

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

229

1.44

1.21

1.1

1.2

40.1

37.5

mg/l

0.21

190

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.16

1.21

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

126

1499

0.84

1.20

1.6

1.7

—

(44813793)

213

1.46

1.20

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

255

1.42

1.19

1.1

1.2

—

(3025315) Body weight

2.31

1.18

7.3

4.1

—

(3016038) Potassium [Moles/volume] in Urine

239

1.43

1.18

1.1

28.6

34.4

mmol/l

1.00

202

(3032773) Endomysium IgG Ab [Titer] in Serum

274

1.39

1.15

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

124

1042

1.20

1.15

1.5

1.6

1.2

3.2

iu/ml

0.30

216

(40757373) Influenza virus identified in Isolate

1.81

1.15

1.7

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

386

1.32

1.14

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

216

1.44

1.13

1.1

—

(1761868) Lipid panel - Serum or Plasma

1204

11492

1.07

1.12

3.6

3.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

111

1.62

1.12

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

1.48

1.10

1.5

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

277

1.38

1.09

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

320

1.35

1.09

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

243

0.62

1.08

1.0

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

153

1.51

1.06

1.0

1.1

—

4.8

iu/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

1.05

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.06

1.02

1.1

1.5

53.7

26.8

pmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

265

2380

1.12

1.02

1.7

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

122

1.56

1.02

1.2

0.3

g/l

0.25

(3017315) Amylase [Enzymatic activity/volume] in Urine

171

1.46

1.02

1.0

1.2

640.4

284.9

u/l

0.35

156

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

247

1.38

1.01

1.1

1.0

—

(4281824)

188

1.44

1.01

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

109

0.46

1.00

1.2

—

(3022689) Creatine [Moles/volume] in Urine

110

0.45

1.00

1.2

1.4

—

(1616796) Gas panel - Central venous blood

710

1.22

0.99

4.6

3.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

476

1.26

0.98

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

557

1.24

0.98

1.7

1.6

—

(3045788) Cell count panel - Pleural fluid

249

1.37

0.97

1.3

1.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.97

0.0

1.2

—

17.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.97

0.0

1.4

—

21.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

859

0.81

0.97

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

132

1.52

0.97

1.8

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

132

1.52

0.97

1.8

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

629

5903

1.08

0.96

3.2

2.7

0.8

0.7

ug/l

0.79

437

3985

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.85

0.96

1.0

1.1

76.7

54.5

u/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

550

1.24

0.95

1.1

1.2

22.6

27.4

u/l

0.45

471

(3006653) Thiamine [Moles/volume] in Blood

166

1.45

0.94

1.3

134.4

139.7

nmol/l

0.32

166

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

268

1.35

0.94

1.3

1.2

u/ml

0.03

126

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

217

1.39

0.93

1.7

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

789

1.20

0.93

2.0

2.2

129.2

130.0

g/l

0.12

585

(3000034) Microalbumin [Mass/volume] in Urine

362

0.72

0.92

3.0

2.8

67.0

28.4

mg/l

0.35

261

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.14

0.91

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

357

1.29

0.91

1.3

476635.5

99261.8

e6/l

1.04

242

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

408

3774

1.09

0.91

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.63

0.90

1.2

0.8

0.7

umol/24h

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

673

1.21

0.90

3.4

1.9

0.9

0.8

nmol/l

1.32

554

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

298

1.31

0.87

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

858

0.82

0.87

1.7

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.00

0.87

1.0

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

777

1.19

0.86

2.2

2.3

169.3

186.5

1.30

733

(21494755) Public health laboratory ask at order entry panel

232

2567

0.90

0.86

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.82

0.85

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.78

0.84

10.9

11.5

4.1

5.4

mmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

162

1.42

0.84

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.76

0.83

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

129

1.47

0.83

1.5

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

111

0.54

0.83

1.2

1.5

7.1

9.0

ug/l

—

111

(3027923) C peptide [Moles/volume] in Serum or Plasma

188

1.39

0.82

1.4

1.3

0.7

1.3

nmol/l

2.52

146

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.74

0.82

1.0

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

736

1.19

0.81

1.9

1.7

40.0

42.9

nmol/l

0.49

707

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.88

0.81

1.5

1.3

32.0

1166.4

u/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

608

1.20

0.81

5.3

2.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

446

1.24

0.79

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.82

0.79

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

684

0.82

0.78

1.6

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

182

1.38

0.77

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

658

1.19

0.77

1.3

—

(3005570) Glucose [Moles/volume] in Urine

367

1.26

0.77

1.5

2.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.57

0.74

1.4

1.2

584.8

265.9

pmol/l

—

(3006270) Folate [Moles/volume] in Blood

351

1.26

0.74

1.2

353.8

356.1

nmol/l

0.02

296

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

184

1.36

0.73

1.3

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.84

0.73

2.7

2.5

13.0

15.6

ml/dl

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

334

1.26

0.73

1.1

—

45.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

180

1621

1.12

0.73

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

415

1.23

0.73

1.2

1.0

6.2

2.8

u/ml

0.73

177

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.00

0.72

1.0

1.2

—

(3016879) Cocaine [Presence] in Urine

807

0.84

0.72

1.7

1.9

—

(4198724)

110

0.54

0.72

1.8

—

(37021550) Renin [Units/volume] in Plasma --upright

1.58

0.71

1.2

1.3

43.0

61.6

mu/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

232

2535

0.91

0.71

1.7

—

(4212803)

1.92

0.70

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

309

1.26

0.70

1.2

1.1

65.4

59.7

u/l

0.13

204

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.55

0.69

1.0

1.2

—

38.5

—

(36660697) Celiac disease serology panel - Serum

292

2703

1.09

0.68

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

311

1.26

0.67

1.3

1.6

28.6

23.3

u/ml

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

205

1.32

0.67

2.9

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.63

0.66

3.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

583

0.82

0.66

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

348

1.24

0.66

1.1

—

2.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.79

0.66

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.59

0.65

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

872

0.86

0.64

1.7

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

305

1.25

0.63

5.7

3.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

252

1.27

0.62

1.1

1.0

272.1

291.3

mg/l

1.33

223

(4034850)

143

1286

1.12

0.62

12.4

9.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

164

1.34

0.62

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

867

0.86

0.61

1.7

1.9

—

(3012501) Base excess in Blood by calculation

712

1.15

0.61

5.8

4.1

3.1

2.6

mmol/l

0.60

470

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

462

1.19

0.60

1.5

64.6

62.0

0.20

297

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

173

1575

1.10

0.60

6.4

8.7

24.1

24.5

mmol/l

0.80

160

1427

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.60

0.0

1.5

—

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

564

1.17

0.60

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

175

0.68

0.60

1.3

1.5

5.6

4.4

—

(3042517) Benzodiazepines panel - Urine

0.00

0.60

0.0

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.59

0.0

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

131

1.38

0.59

1.3

2.5

180.4

148.2

umol/l

—

(3017569) Oxygen content in Arterial blood

197

0.71

0.58

3.4

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

863

0.87

0.58

1.7

1.9

—

(4268621)

327

1.23

0.58

2.1

2.3

—

(1002224) Polysomnography panel

108

1212

0.89

0.58

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

113

0.62

0.58

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.58

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

173

0.69

0.57

10.0

12.0

952.5

834.3

nmol/l

0.35

166

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

158

1.33

0.57

1.5

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

1.48

0.57

1.0

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

171

1565

1.10

0.55

3.8

3.9

24.0

24.2

mmol/l

0.43

145

1384

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

505

1.17

0.54

2.0

1.9

199.8

197.1

pmol/l

0.06

481

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

468

1.18

0.54

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.58

0.54

1.0

1.2

1.7

umol/24h

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.58

0.54

3.2

11.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.54

1.0

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

322

1.21

0.53

1.5

1.3

0.4

g/l

0.26

225

(3028192) IgG subclass 2 [Mass/volume] in Serum

322

1.21

0.53

1.5

1.3

2.8

g/l

0.01

222

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.54

0.53

1.7

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

108

1.39

0.53

1.4

1.3

41.6

31.6

—

(4062490)

323

1.21

0.52

1.5

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

323

1.21

0.52

1.5

1.3

5.8

6.7

g/l

1.01

225

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.45

0.51

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.50

0.51

1.2

—

(3045424) Erythrocytes [Presence] in Urine

583

1.15

0.51

1.3

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

696

1.14

0.51

1.6

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

188

1.28

0.51

1.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

716

1.13

0.50

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

716

1.13

0.50

1.4

1.3

—

(3008898) HLA-B27 [Presence]

118

1068

1.11

0.49

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

257

0.78

0.49

1.1

1.2

275.0

195.2

titre

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.49

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.49

0.47

2.9

2.4

—

(3018133) Calcium [Moles/volume] in Urine

1.49

0.47

1.7

1.9

3.6

3.1

mmol/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

290

1.21

0.47

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.41

0.46

1.1

102.3

87.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.46

0.46

1.1

—

(4027681)

173

1.27

0.46

1.5

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

702

1.13

0.46

1.3

1.2

22.7

42.8

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

355

3370

1.06

0.46

4.0

3.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

342

0.82

0.45

1.2

1.1

4.5

4.1

u/ml

—

137

(4024509)

384

1.17

0.45

1.3

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

103

1.36

0.45

1.3

1.4

—

1431193.8

—

(3016018) Differential panel - Cerebral spinal fluid

329

1.19

0.45

1.5

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1500

14697

1.03

0.44

10.8

8.4

0.0

e9/l

0.75

1249

11975

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.37

0.44

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

160

1727

0.92

0.44

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

1.31

0.43

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

130

1.31

0.43

1.9

2.6

26.6

29.1

umol/l

0.39

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

175

1.26

0.43

1.0

—

(3025130) Human papilloma virus identified in Specimen

396

1.16

0.42

2.1

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

382

0.84

0.42

1.6

2.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

122

1.31

0.42

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

500

1.14

0.41

1.4

1.6

0.6

0.8

g/l

1.72

371

(3020191) Ethanol [Moles/volume] in Serum or Plasma

258

1.20

0.41

1.4

1.2

promille

0.02

199

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

176

1.25

0.41

1.0

—

(3024928) Oxygen saturation in Venous blood

711

0.88

0.41

2.6

3.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

2.1

—

3.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.47

0.40

1.2

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.47

0.40

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.36

0.40

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.36

0.40

1.3

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

484

1.14

0.39

1.1

1.2

3.2

u/ml

2.03

157

(3007566) Smooth muscle Ab [Titer] in Serum

855

1.10

0.39

1.2

98.0

94.3

titre

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.38

0.38

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.36

0.38

1.1

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

192

0.78

0.38

1.2

1.3

5.8

5.9

mmol/l

0.15

184

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

458

1.14

0.37

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.35

0.37

1.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

170

1.24

0.37

1.2

1.1

1.0

1.1

u/l

1.17

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

915

9376

0.97

0.36

1.7

1.6

1.3

mmol/l

0.26

760

7814

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

469

1.13

0.36

1.1

1.2

4.6

5.2

u/ml

0.09

197

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.66

0.35

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.65

0.35

1.6

1.9

—

(3011288) Drugs identified in Urine by Screen method

586

0.89

0.35

1.9

2.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.37

0.34

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

372

0.86

0.33

1.1

1.7

3.1

u/ml

0.54

147

(3027456) Digoxin [Moles/volume] in Serum or Plasma

825

1.09

0.33

4.2

3.2

0.8

nmol/l

1.35

636

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.33

1.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

177

0.79

0.33

16.1

16.3

1525.7

1465.8

nmol/l

0.11

172

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.30

0.33

1.2

1.4

—

(4094501)

946

0.92

0.32

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

108

1004

1.08

0.30

1.4

—

(3010421) pH of Blood

840

1.09

0.30

5.8

3.9

7.4

0.41

697

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.30

0.30

2.1

1.5

102.7

125.2

ug/l

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.31

0.30

1.1

103.8

90.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

102

1.28

0.30

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

157

1.21

0.29

3.1

4.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

118

1103

1.07

0.29

1.6

1.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

185

1.19

0.29

1.6

1.5

7.6

6.0

u/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

176

1.19

0.28

2.0

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

184

0.81

0.28

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

0.80

0.28

1.0

1.1

—

(3019977) pH of Arterial blood

194

0.82

0.27

3.0

2.4

7.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

119

0.76

0.27

2.7

2.6

173.6

163.0

nmol/l

—

104

(3006576) Bicarbonate [Moles/volume] in Blood

121

0.74

0.27

8.4

7.0

23.7

25.2

mmol/l

—

109

(3033799) Differential panel - Peritoneal fluid

1.23

0.27

1.6

2.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

471

1.11

0.26

1.1

2.9

5.0

u/ml

1.20

237

(3040151) Glucose [Moles/volume] in Capillary blood

395

1.12

0.26

7.1

7.7

9.7

7.5

mmol/l

0.28

323

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

364

3522

1.04

0.26

1.8

1.7

1.5

0.10

320

3080

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

114

1071

1.07

0.26

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

602

0.91

0.25

1.5

—

(3036489) Thrombin time

118

1113

1.06

0.24

1.9

21.3

20.9

0.47

108

963

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

276

0.87

0.24

1.0

36.7

46.6

ng/l

0.76

174

(3051101) Glucose [Moles/volume] in Cord blood

0.74

0.24

6.2

—

(3014051) Protein [Presence] in Urine by Test strip

832

1.07

0.24

2.6

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

119

1124

1.06

0.23

4.2

1.5

0.9

0.4

g/l

0.71

951

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

412

0.90

0.23

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

456

1.10

0.23

1.1

0.7

1.1

u/ml

0.44

189

(3051593) INR in Capillary blood by Coagulation assay

190

0.84

0.23

8.2

11.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.32

0.23

1.6

60.4

47.9

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

476

1.09

0.23

1.8

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

409

1.10

0.22

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1.13

0.22

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1.13

0.22

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1.13

0.22

1.2

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.25

0.22

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.22

0.22

2.6

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

305

0.88

0.22

1.2

1.1

0.1

0.4

u/ml

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

273

0.88

0.21

1.0

682.3

697.4

ng/l

0.06

168

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

3.4

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

1.7

—

1104.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.21

0.0

1.0

—

7.9

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.8

—

363.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.16

0.21

1.2

2.3

—

(3014891) Appearance of Pleural fluid

1.16

0.21

1.4

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

6.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(4306422)

460

1.09

0.20

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

24.4

—

(40767503) Oxygen content in Capillary blood by calculation

693

1.07

0.20

2.7

2.5

16.1

16.3

0.15

370

(3021788) Differential panel - Synovial fluid

664

1.07

0.20

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

212

1.13

0.19

1.0

1.1

2.7

7.2

nmol/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

147

1.16

0.18

1.9

1.3

—

(3023410) Appearance of Cerebral spinal fluid

300

0.90

0.18

1.6

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

455

0.92

0.17

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

484

1.08

0.17

1.8

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

465

0.92

0.17

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

243

1.11

0.17

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

243

1.11

0.17

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.11

0.17

2.1

2.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

582

1.07

0.17

1.2

—

(3020491) Glucose [Moles/volume] in Blood

263

1.10

0.16

1.7

2.3

7.4

6.5

mmol/l

0.80

174

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.14

0.16

1.3

1.5

113.3

116.2

ng/l

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

244

1.11

0.16

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.13

0.16

2.1

1.6

—

(3011648) Oxygen content in Venous blood

256

0.90

0.16

2.4

2.2

9.9

11.0

0.62

256

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

260

2534

1.03

0.15

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

111

1065

1.04

0.15

3.9

1.4

36.5

37.6

g/l

1.05

881

(3044941) Cell count panel - Synovial fluid

595

1.06

0.15

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

410

1.07

0.15

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.80

0.14

6.3

7.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

131

1.15

0.14

1.1

1100.3

1569.0

miu/ml

0.99

131

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

164

1589

1.03

0.14

1.6

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

725

1.05

0.13

1.4

1.3

9.8

27.3

e6/l

0.97

566

(40761536) Microorganisms panel - Urine sediment

272

2781

0.98

0.13

5.4

3.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

569

1.06

0.13

1.3

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

117

0.85

0.13

1.2

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

107

0.84

0.13

3.4

2.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

726

1.05

0.13

1.4

843.7

1218.8

e6/l

0.27

599

(3004451) EKG impression Narrative

172

1.11

0.11

1.4

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

271

0.92

0.11

1.0

399.4

345.2

ng/l

0.23

175

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

926

1.04

0.11

4.3

1.4

0.0

g/l

0.00

833

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

407

1.06

0.10

1.4

1.5

—

(3000492) Spirometry study

316

3111

1.02

0.09

1.7

1.5

—

(3005033) Fetal Nuchal fold Thickness US

452

0.95

0.09

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

134

0.90

0.08

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

146

1.10

0.08

2.0

1.3

—

(3024263) Appearance of Synovial fluid

195

0.92

0.08

1.8

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.03

0.07

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.86

0.07

1.0

1.6

—

(4133840)

0.87

0.07

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.86

0.06

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

0.92

0.06

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

433

1.04

0.06

1.1

1.3

7.1

7.5

mmol/l

0.27

308

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

0.88

0.06

1.0

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

0.88

0.06

1.0

2.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

910

1.02

0.05

4.4

1.4

0.0

g/l

0.00

829

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

182

0.93

0.05

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

514

1.03

0.05

1.1

2.3

1228.1

iu/ml

—

109

(3010726) Horse dander IgE Ab [Units/volume] in Serum

425

0.96

0.05

1.1

1.8

2.9

u/ml

—

103

(3015183) Erythrocyte sedimentation rate

151

0.93

0.05

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

818

0.98

0.05

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

129

1269

1.02

0.05

1.5

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

272

0.96

0.04

1.8

1.9

3.1

3.8

ug/l

0.38

239

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

299

0.97

0.02

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

550

1.02

0.02

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

549

0.98

0.02

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

163

1.04

0.01

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

108

1088

0.99

0.01

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

100

994

1.01

0.00

4.2

1.4

0.0

g/l

1.38

899

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

102

0.98

0.00

1.4

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

198

1.01

0.00

2.1

1.7

—

(3025577) Chromium [Mass/volume] in Blood

262

0.99

0.00

2.0

2.5

ug/l

0.02

221

(3035320) C reactive protein [Mass/volume] in Body fluid

235

1.02

0.00

2.1

2.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

538

1.00

0.00

1.2

1.1

2.3

1.5

u/ml

0.15

208

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

552

1.00

0.00

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

106

1.04

0.00

1.2

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

136

1.03

0.00

1.5

2.0

16.4

273.7

ug/l

0.67

126

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

174

0.98

0.00

1.4

1.6

8.2

7.8

mmol/l

—

104

(3000012) Reticulocyte production index

184

0.98

0.00

1.7

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

137

1.02

0.00

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

364

0.99

0.00

1.8

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

467

1.01

0.00

1.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

119

1.01

0.00

1.2

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

551

1.00

0.00

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

117

1169

1.00

0.00

1.7

3.5

3.7

mg/l

0.07

825

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.91

0.00

2.0

16.7

16.5

umol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.96

0.00

1.4

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

330

1.00

0.00

1.3

1.5

32.4

29.8

0.14

211

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.00

0.00

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.3

—

0.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.93

0.00

6.3

7.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

3.5

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.94

0.00

1.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

4.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.01

0.00

2.0

3.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.02

0.00

1.5

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.94

0.00

1.6

1.7

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

4.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.94

0.00

1.4

1.8

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(4038314)

0.00

0.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

124.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

6.8

—

(3000285) Sodium [Moles/volume] in Blood

0.89

0.00

1.4

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

174.6

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

9.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.6

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

43.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_SKIN_FACE_EXALLC – Benign neoplasm: Skin of other and unspecified parts of face

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Skin of other and unspecified parts of face

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints